Stay updated with breaking news from M Technology Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For the second year in a row, the University of Minnesota’s research enterprise exceeded $1 billion in competitively earned sponsored research awards.
With a focus on student access and affordability, public safety and core operations, the Board of Regents approved the University's biennial legislative request at its October meeting
Combination of current UMN DEI programming and systemwide enhancements to be discussed by Board of Regents
University of Minnesota Medical School researchers say ''tumor-secreted exosomes'' help some cancer cells to evade immune response of current FDA-approved treatment options.
New exosome-based therapeutic strategy to potentially treat late-stage colorectal cancer In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States. The team identified a novel mechanism by which colorectal cancer cells evade an anti-tumor immune response, which helped them develop an exosome-based therapeutic strategy to potentially treat the disease. Late-stage colorectal cancer patients face enormous challenges with...